Pharmacokinetics of Ridaforolimus (MK-8669) in Chinese Participants (MK-8669-059)

Clinical trial NCT01380184 · COMPLETED

Trial details

NCT number: NCT01380184
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer, Advanced

Start date: 2011-07-05
Primary completion: 2011-10-20
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.